[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346792-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-346792-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","18f-fdg-petct-negative-gastric-cancer-employs-glutamine-based-gluconeogenesis-and-fatty-acid-oxidation-to-support-tumor-growth","18F-FDG-PET/CT-negative gastric cancer employs glutamine-based gluconeogenesis and fatty acid oxidation to support tumor growth","","18F-FDG-PET/CT-negative gastric cancers rely on metabolic rewiring to sustain growth despite low glucose uptake. The study identifies coordinated glutamine-based gluconeogenesis and fatty acid oxidation as key pathways meeting DNA and ATP demands. PCK and CPT1A are highly expressed, correlating negatively with FDG imaging levels and with worse clinical classifications. Mechanistically, PPARγ promotes transcription of PCK and related genes, and pharmacologic PCK/CPT1A inhibition suppresses tumor growth in CDX and PDX models, supporting targeted metabolic precision therapy.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/18f-fdg-petct-negative-gastric-cancer-employs-glutamine-based-gluconeogenesis-and-fatty-acid-oxidation-to-support-tumor-growth/346792/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/18f-fdg-petct-negative-gastric-cancer-employs-glutamine-based-gluconeogenesis-and-fatty-acid-oxidation-to-support-tumor-growth/346792.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"Why is 18F-FDG-PET/CT negative gastric cancer clinically important?","Question",{"text":63,"@type":64},"Many gastric cancer cases show negative 18F-FDG-PET/CT findings, which limits diagnostic utility and prompts investigation of alternative metabolic strategies beyond aerobic glycolysis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What metabolic pathways support tumor growth in FDG-PET/CT-negative gastric cancer?",{"text":68,"@type":64},"The findings show coordination of glutamine-based gluconeogenesis and fatty acid oxidation to satisfy DNA and ATP requirements while glucose uptake remains low.",{"name":70,"@type":61,"acceptedAnswer":71},"How do PCK and CPT1A relate to FDG imaging and clinical severity?",{"text":72,"@type":64},"PCK/CPT1A are highly expressed in FDG-PET/CT-negative tumors, negatively correlate with 18F-FDG imaging levels, and associate with poorer clinical classifications.",{"name":74,"@type":61,"acceptedAnswer":75},"What is the proposed mechanism and therapeutic implication of targeting PCK/CPT1A?",{"text":76,"@type":64},"PPARγ drives transcription of PCK and genes involved in the metabolic program; inhibiting PCK/CPT1A significantly suppresses tumor growth in CDX and PDX models, indicating a target for metabolic precision therapy.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},346792,1790497047,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \n18F-FDG-PET/CT-negative gastric cancer employs glutaminebased gluconeogenesis and fatty acid oxidation to support tumor growth  \nJia Liu1,3, Mingjie Xia2,3, Zhexuan Zhao1,3, Tian Gao 1, Yanzhao Qu 1, Qian Wang 1, Xiangdan Liu1, Jianlan Du 1, Shunxin Han 1, Shiying Yang 1, Min Wei 1, Xin Jin 1 ✉ and Yang Wang 1 ✉  \n© The Author(s) 2026  \n|  |  |  |\n| --- | --- | --- |\n|  | Most tumors exhibit increased glucose uptake and reprogram metabolism to aerobic glycolysis to meet their demands for macromolecule biosynthesis and energy production. Consequently, PET/CT using 18F-2-ﬂuoro-2-deoxy-D-glucose (18F-FDG-PET/CT) has been developed and is clinically utilized in cancer imaging diagnostics. However, numerous cancers demonstrate negative imaging during 18F-FDG-PET/CT detection, suggesting these cancers employ alternative metabolic rewiring. In this study, we discovered that 18F-FDG-PET/CT-negative gastric cancers coordinate glutamine-based gluconeogenesis and fatty acid oxidation to meet DNA and ATP demands, sustaining tumor growth despite low glucose uptake. PCK and CPT1A, the key enzymes which are responsible for remodeling the metabolism, were highly expressed in FDG-PET/CT-negative gastric cancers. Accordingly, PCK/ CPT1A negatively correlated with 18F-FDG imaging levels and positively correlated with poorer clinical classiﬁcations.\u003Cbr>Mechanistically, PPARγ is highly expressed in FDG-PET/CT-negative cells and drives the transcription of the PCK and genes. Pharmacological inhibition of the PCK/CPT1A signiﬁcantly suppressed tumor growth in 18F-FDG-PET/CT-negative gastric cancers, as demonstrated in both cell-derived xenograft (CDX) and patient-derived xenograft (PDX) models. Together, these results highlight the heterogeneity of tumor cells from metabolic perspective, and identify PCK/CPT1A as a target for metabolic reprogramming and |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| precision therapy of 18F-FDG-PET/CT-negative cancers. |  |  |\n|  | Cell Death and Disease (2026)17:365; [https://doi.org/10.1038/s41419-026-08662-9](https://doi.org/10.1038/s41419-026-08662-9) |  |\n|  |  |  |\n\nINTRODUCTION  \nMetabolic reprogramming is a hallmark of tumor cells [1–4] . The Warburg effect, also known as aerobic glycolysis [2], is the most well-characterized phenomenon associated with metabolic reprogramming in tumor cells. Typically, glycolysis is a physiological response to hypoxia in normal tissues. However, in the 1920s, Otto Warburg observed that cancer cells in tumor slices and ascites constitutively take up glucose and switch glucose metabolism from oxidative phosphorylation to glycolysis. As a result, these cells produce lactate even under normal oxygen concentrations. This shift in glucose metabolism to glycolysis allows glycolytic intermediates to supply glycolytic shunts, thereby fueling the synthesis of macromolecules such as DNA, lipids, and proteins [2] . Therefore, aerobic glycolysis meets the biosynthetic demands required to support the rapid and sustainable proliferation of cancer cells. This phenomenon has been observed in various types of cancer cells and tumors to date [5–7] .  \nBased on the phenomenon of aerobic glycolysis, 18F-2-ﬂuoro-2-deoxy-D-glucose (18F-FDG), a glucose analog, has become the most widely used radiotracer for the detection of malignancies in combination with positron emission tomography (PET)/computed  \ntomography (CT) . Brieﬂy, 18F-FDG is intravenously injected into the patient and is then rapidly taken up by tumor cells. It is subsequently phosphorylated to form 6-phosphate FDG, which cannot be further metabolized and thus accumulates continuously within cancer cells. This accumulation can be imaged using PET/CT to indicate cancer focus. Speciﬁcally, 18F-FDG-PET/CT is capable of detecting distant metastases and thereby enhances the accuracy and speciﬁcity of","cbCaicrkluVsmpyH","https://ap.wps.com/l/cbCaicrkluVsmpyH","pdf",8490967,14,"English","# Introduction\n## Metabolic reprogramming and the Warburg effect\n## Principles and clinical use of 18F-FDG PET/CT\n## Gastric cancer incidence and the challenge of FDG-negative imaging","[{\"question\":\"Why is 18F-FDG-PET/CT negative gastric cancer clinically important?\",\"answer\":\"Many gastric cancer cases show negative 18F-FDG-PET/CT findings, which limits diagnostic utility and prompts investigation of alternative metabolic strategies beyond aerobic glycolysis.\"},{\"question\":\"What metabolic pathways support tumor growth in FDG-PET/CT-negative gastric cancer?\",\"answer\":\"The findings show coordination of glutamine-based gluconeogenesis and fatty acid oxidation to satisfy DNA and ATP requirements while glucose uptake remains low.\"},{\"question\":\"How do PCK and CPT1A relate to FDG imaging and clinical severity?\",\"answer\":\"PCK/CPT1A are highly expressed in FDG-PET/CT-negative tumors, negatively correlate with 18F-FDG imaging levels, and associate with poorer clinical classifications.\"},{\"question\":\"What is the proposed mechanism and therapeutic implication of targeting PCK/CPT1A?\",\"answer\":\"PPARγ drives transcription of PCK and genes involved in the metabolic program; inhibiting PCK/CPT1A significantly suppresses tumor growth in CDX and PDX models, indicating a target for metabolic precision therapy.\"}]","18F-FDG-PET/CT-negative gastric cancer employs glutamine-based gluconeogenesis and fatty acid oxidation to support tumor growth | PDF",1790062767,35,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f02acddde8a80853dabff5eeb91cb33.webp",983,1305,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/69a9e4a7662da773641a0826fa4a70b3.webp",982,1304,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e870156d6f1ce9ff9a50e424b3b099d6.webp",981,1303,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d74b7b085df973e82da2206ef74f4874.webp",980,1301]